Your money or their life. Drug to combat blood pressure may come at a price, but the wider health benefits should not be underestimated, says Nick Summerton.
New anti-hypertensive drugs, although more expensive than conventional treatments, have significant benefits in the management of cardiovascular disease. NICE analysis of cost-benefits don't consider their impact on other risk factors for cardiovascular disease, such as diabetes. A broader perspective is necessary when assessing the public health of anti-hypertensive drugs.
Summerton
Nick
N
University of Hull.
D000959:Antihypertensive Agents / Q000191:economics* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D012307:Risk Factors; D013222:State Medicine; D006113:United Kingdom
D000959:Antihypertensive Agents